Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Danish court overturns Lipitor patent challenge

September 5, 2008
Sales and Marketing Denmark, Lipitor, Pfizer, generics

A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …

News

Pfizer to co-market new Alzheimer’s drug

September 5, 2008
Sales and Marketing Alzheimer's, Pfizer

 Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …

News

Latest news from Datamonitor

September 1, 2008
Research and Development Pfizer

Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …

News

Groundbreaking pharma-NHS collaboration launched in Nottingham

May 30, 2008
ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working

A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …

News

Pfizer invests in oncology for future gains

May 16, 2008
Research and Development, Sales and Marketing Cancer, Pfizer

Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …

News

Pfizer abandons Exubera

October 19, 2007
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …

News

Wyeth names new chief executive

October 10, 2007
Sales and Marketing Pfizer, Wyeth

Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …

News

Pfizer appoints new finance chief

August 23, 2007
Sales and Marketing Pfizer

Pfizer has appointed Frank D'Amelio as its new head of finance, and says he has a strong track record in …

News

Latest news from Datamonitor

June 22, 2007
Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …

News

Pfizer’s torcetrapib results cast doubt on CETP inhibitors

March 30, 2007
Research and Development, Sales and Marketing Pfizer, lipid

New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …

News

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

News

Kindler sets out new vision for Pfizer

December 1, 2006
Sales and Marketing Pfizer, lipid

Pfizer's chief executive Jeffrey Kindler has set out plans for the company to renew itself as an R&D, in-licensing and …

News

Pfizer cuts 2,200 US sales reps

December 1, 2006
Sales and Marketing Pfizer, US, job cuts, salesforce

 Pfizer has announced a cut of 20% to its US salesforce, a move it says will help it adapt to …

News

Pfizer buys British vaccine company PowderMed

October 12, 2006
Research and Development Pfizer, Powdermed, vaccines

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …

News

McKinnell makes early exit from Pfizer

August 3, 2006
Sales and Marketing Pfizer

Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026